Earnings Call · Q3 FY2024·2024-11-06

Q3 24EPS +11.63%·Rev n/aQ2 24EPS +40.30%·Rev n/aQ1 24EPS -100.00%*·Rev n/aQ4 23EPS -100.00%*·Rev n/a⚠ consensus missing

LENZ Therapeutics, Inc. LENZ

Dan Chevallard — Chief Financial Officer

Eef Schimmelpennink — President and Chief Executive Officer

Shawn Olsson — Chief Commercial Officer

+12.5%1d on move date+10.0% vs SPY3d+22.4%5d+30.0%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more LENZ calls or request research access.

More LENZ calls Browse calls Request research access